We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pierrel | BIT:PRL | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Dec 2022 to Dec 2024
By Colin Kellaher
3M Co. on Tuesday said it agreed to sell a handful of dental local anesthetic products to Italy's Pierrel for $70 million.
The St. Paul, Minn., conglomerate, which last week unveiled plans to shed about 6,000 jobs in a global restructuring, said the products generated sales of about $30 million last year and weren't material to its financial results.
3M said the products, which it sells mainly in Europe and Asia, include those sold under the Ubistesin, Xylestesin and Mepivastesin brands and are part of its oral-care business.
The company said it expects to record a gain on the sale, which it expects to complete in the third quarter, adding that it will retain the ownership of its plant in Seefeld, Germany, where the portfolio is based.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 02, 2023 12:49 ET (16:49 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Pierrel Chart |
1 Month Pierrel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
